Decoding China’s Health Insurance & National Reimbursement Drug List (NRDL)

May. 16th, 2023

Grace Wang


China’s health insurance and National Reimbursement Drug List (NRDL) are significant for innovative drug products to reach the market in hospitals. Reimbursement makes innovative drugs, usually at high prices, to be more affordable to patients.

For pharmaceutical companies, earning a place in the NRDL is an approach to widen market access for their drug products. But does NRDL listing a guarantee of sales growth? What is the role of NRDL, a list of drugs adjusted almost annually, in the market dynamics? This webinar organized by ChemLinked BaiPharm Portal is going to answer the questions.


1. China’s Health Insurance System

1.1 Social health insurance and commercial health insurance

1.2 How do Chinese citizens get access to healthcare covered/reimbursed drugs

1.3 Reimbursement rate varies in different regions

2. China’s National Reimbursement Drug List (NRDL)

2.1 What is NRDL?

2.2 How does drugs get into NRDL? NHSA selection or negotiation

2.3 Analysis of every round of NRDL negotiations: price cuts, numbers of listed drugs, therapeutic areas, etc.

2.4 Highlighted products in the current version of NRDL

2.5 What’s the process for NRDL-listed drugs to be procured by hospitals?

2.6 How does NRDL listing influence the relevant drug’s sales volume and market share?

2.7 Should pharmaceutical companies try to get their products listed in NRDL? Pros & cons and how to get listed.


Date Time (GMT+8) World Clock Language
2023-05-16 21:00 ~ 22:00 London: 14:00-15:00
New York: 9:00-10:00


Grace Wang

ChemLinked Regulatory Analyst / Editor

Grace Wang is a regulatory analyst and editor specializing in China’s pharmaceutical regulations and market trends. She provides articles and webinars to help overseas pharma companies enter the Chinese market. Her areas of focus include DMF filing, NDA, ANDA, pharmacovigilance, health insurance, and volume-based procurement (VBP).

Contact Us

If you have any questions about this webinar, don’t hesitate to get in touch with us:

Tel: +86 400 809 5809